Provided by Tiger Trade Technology Pte. Ltd.

Praxis Precision Medicines, Inc.

334.58
-3.9900-1.18%
Post-market: 334.50-0.0800-0.02%19:54 EDT
Volume:175.39K
Turnover:59.39M
Market Cap:9.32B
PE:-26.01
High:348.00
Open:340.00
Low:334.00
Close:338.57
52wk High:392.70
52wk Low:37.25
Shares:27.85M
Float Shares:24.08M
Volume Ratio:0.71
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8634
EPS(LYR):-13.4758
ROE:-38.86%
ROA:-25.65%
PB:6.95
PE(LYR):-24.83

Loading ...

Praxis Precision Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 06

Praxis Precision Net Loss Widens 17.7% to $83.72 Million in Q2 FY26

Reuters
·
Aug 06

Earnings Flash (PRAX) Praxis Precision Medicines Posts Q2 Loss $2.87 a Share, vs. FactSet Est of $3.64 Loss

MT Newswires Live
·
Aug 06

Praxis Precision Medicine Q2 EPS $(2.87) Beats $(3.65) Estimate

Benzinga Earnings
·
Aug 06

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 06

Praxis Precision Q2 EPS USD -2.87

THOMSON REUTERS
·
Aug 06

Praxis Precision Q2 Operating Expenses USD 96.904 Million

THOMSON REUTERS
·
Aug 06

Praxis Precision Medicines Grants 7,318 RSUs to 29 New Employees Under 2024 Inducement Plan

Reuters
·
Aug 05

Praxis Precision Medicines, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 05

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 05

Praxis Precision Medicines Inc Expected to Post a Loss of $3.66 a Share - Earnings Preview

Reuters
·
Aug 04

Praxis Extends Vormatrogine Epilepsy Trial, Keeping Long-Term Growth Story in Play

TIPRANKS
·
Aug 04

Praxis Advances PRAX-628 Tablet Formulation in Completed Bioavailability Study

TIPRANKS
·
Aug 04

Praxis Precision Med Price Target Maintained with a $810.00/Share by BTIG

Dow Jones
·
Jul 29

Praxis Precision Medicines (PRAX) Has a New Rating from Goldman Sachs

TIPRANKS
·
Jul 21

Praxis Precision Medicines (PRAX) Could Be 49% Undervalued As Patch Deal Expands Ulixacaltamide Reach

Simply Wall St.
·
Jul 20

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jul 14

Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)

TIPRANKS
·
Jul 13

Goldman Sachs Initiates Praxis Precision Medicines at Buy With $447 Price Target

MT Newswires Live
·
Jul 13

S&P 500 Futures Decline in Premarket Trading; SK Hynix ADR, MKS Lag

Dow Jones
·
Jul 13